Delfini Lisa

Chief Financial Officer

1 company

Average

Trades Analyzed

12M Win Rate

20.0%

Avg 3M Return

+9.0%

Avg 12M Return

-29.5%

Delfini Lisa is a Chief Financial Officer at Trevi Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 10 sells.

Estimated insider holdings value: $978K based on current market prices.

Holdings by Company

TRVIJan 8, 2025

Current Shares64.7K

Value$978.0K

Net Activity-18,593

Bought: 0Sold: 18.6K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 22, 2024	TRVI Trevi Therapeutics, Inc.	Chief Financial Officer	Sale+OE	4,350	$2.64	$11,484.87	-7.5%	+7.5%	+127.5%
Oct 11, 2023	TRVI Trevi Therapeutics, Inc.	Chief Financial Officer	Sale+OE	785	$2.02	$1,585.70	-2.1%	-33.8%	+47.1%
Sep 11, 2023	TRVI Trevi Therapeutics, Inc.	Chief Financial Officer	Sale+OE	711	$2.20	$1,564.20	-2.0%	-49.1%	+39.4%
Aug 11, 2023	TRVI Trevi Therapeutics, Inc.	Chief Financial Officer	Sale+OE	682	$2.36	$1,609.52	-2.0%	-43.1%	+20.2%
Jul 11, 2023	TRVI Trevi Therapeutics, Inc.	Chief Financial Officer	Sale+OE	687	$2.34	$1,607.58	-2.2%	-10.1%	+16.7%
Jun 12, 2023	TRVI Trevi Therapeutics, Inc.	Chief Financial Officer	Sale+OE	610	$2.64	$1,610.40	-2.0%	-11.7%	+1.6%
May 11, 2023	TRVI Trevi Therapeutics, Inc.	Chief Financial Officer	Sale+OE	562	$2.89	$1,624.18	-2.0%	-23.0%	-9.0%
Apr 11, 2023	TRVI Trevi Therapeutics, Inc.	Chief Financial Officer	Sale+OE	840	$1.84	$1,544.76	-3.1%	+29.0%	+49.2%
Mar 13, 2023	TRVI Trevi Therapeutics, Inc.	Chief Financial Officer	Sale+OE	892	$1.75	$1,563.85	-3.5%	+36.9%	+54.5%
Feb 13, 2023	TRVI Trevi Therapeutics, Inc.	Chief Financial Officer	Sale+OE	8,474	$2.45	$20,761.30	-26.6%	+7.8%	-24.9%